Ming Tan

1.3k total citations
38 papers, 957 citations indexed

About

Ming Tan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ming Tan has authored 38 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Surgery. Recurrent topics in Ming Tan's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer therapeutics and mechanisms (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Ming Tan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer therapeutics and mechanisms (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). Ming Tan collaborates with scholars based in United States, China and Denmark. Ming Tan's co-authors include Clinton F. Stewart, Ove B. Schaffalitzky de Muckadell, Peter J. Houghton, Mark N. Kirstein, Tiebin Liu, Stig Borbjerg Laursen, Mao Ye, William H. Meyer, Ji‐Kai Liu and John C. Panetta and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ming Tan

37 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Tan United States 16 401 289 234 146 109 38 957
Diana Stempak Canada 16 380 0.9× 254 0.9× 202 0.9× 126 0.9× 87 0.8× 22 975
Megumi Baba Japan 19 395 1.0× 294 1.0× 197 0.8× 167 1.1× 67 0.6× 48 977
Fei Cao China 20 600 1.5× 333 1.2× 254 1.1× 239 1.6× 40 0.4× 77 1.4k
Claudio Zanna Switzerland 19 411 1.0× 862 3.0× 166 0.7× 205 1.4× 35 0.3× 49 1.4k
Álmos Klekner Hungary 20 389 1.0× 127 0.4× 89 0.4× 91 0.6× 68 0.6× 59 891
Miki Nishimura Japan 18 422 1.1× 264 0.9× 121 0.5× 105 0.7× 26 0.2× 49 1.1k
Nektaria Makrilia Greece 15 280 0.7× 325 1.1× 287 1.2× 126 0.9× 183 1.7× 23 1.0k
Christopher Mohr Germany 21 746 1.9× 157 0.5× 161 0.7× 390 2.7× 64 0.6× 64 1.6k
Theodore Lagattuta United States 16 650 1.6× 314 1.1× 213 0.9× 54 0.4× 41 0.4× 30 1.4k
L.L. Miller United States 13 335 0.8× 332 1.1× 229 1.0× 70 0.5× 29 0.3× 30 900

Countries citing papers authored by Ming Tan

Since Specialization
Citations

This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).

Fields of papers citing papers by Ming Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.

Co-authorship network of co-authors of Ming Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Tan. A scholar is included among the top collaborators of Ming Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Tan. Ming Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Ming, Klaus Brusgaard, Anne‐Marie Gerdes, et al.. (2021). Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients. Clinical Genetics. 100(5). 551–562. 8 indexed citations
2.
Tan, Ming, Thøger Gorm Jensen, Stig Lønberg Nielsen, Ove B. Schaffalitzky de Muckadell, & Stig Borbjerg Laursen. (2021). Analysis of patterns of bacteremia and 30-day mortality in patients with acute cholangitis over a 25-year period. Scandinavian Journal of Gastroenterology. 56(5). 578–584. 7 indexed citations
3.
Tan, Ming, et al.. (2020). Gene Expression Network Analysis of Precursor Lesions in Familial Pancreatic Cancer. SHILAP Revista de lepidopterología. 6(1). 73–84. 16 indexed citations
4.
5.
Sundararajan, Vignesh, Ming Tan, Tuan Zea Tan, et al.. (2020). SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers. 12(5). 1140–1140. 11 indexed citations
6.
Herzog, Torsten, Ming Tan, Orlin Belyaev, Andreas Minh Luu, & W. Uhl. (2019). Bile duct infections with multidrug resistant microorganisms in pancreatic surgery. HPB. 21. S683–S684. 1 indexed citations
7.
Sundararajan, Vignesh, Ming Tan, Tuan Zea Tan, et al.. (2019). SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition. Scientific Reports. 9(1). 8295–8295. 31 indexed citations
8.
Tan, Ming, Ove B. Schaffalitzky de Muckadell, & Stig Borbjerg Laursen. (2019). Unchanged mortality in patients with acute cholangitis despite an increase in malignant etiologies – a 25-year epidemiological study. Scandinavian Journal of Gastroenterology. 54(3). 335–341. 10 indexed citations
9.
Sng, Ban Leong, et al.. (2017). Incidence and risk factors for epidural re-siting in parturients with breakthrough pain during labour epidural analgesia: a cohort study. International Journal of Obstetric Anesthesia. 34. 28–36. 8 indexed citations
10.
Tan, Bibo, Yong Li, Xiaoming Shi, et al.. (2017). Expression of Vav3 protein and its prognostic value in patients with gastric cancer. Pathology - Research and Practice. 213(5). 435–440. 7 indexed citations
11.
Tan, Ming, Ove B. Schaffalitzky de Muckadell, & Stig Borbjerg Laursen. (2017). Association between early ERCP and mortality in patients with acute cholangitis. Gastrointestinal Endoscopy. 87(1). 185–192. 46 indexed citations
12.
Wu, Dong, Ming Tan, Meiling Zhou, et al.. (2014). Liver Computed Tomographic Perfusion in the Assessment of Microvascular Invasion in Patients With Small Hepatocellular Carcinoma. Investigative Radiology. 50(4). 188–194. 31 indexed citations
13.
Tan, Bao Zhen, Fengli Jiang, Ming Tan, et al.. (2011). Functional Characterization of Alternative Splicing in the C Terminus of L-type CaV1.3 Channels. Journal of Biological Chemistry. 286(49). 42725–42735. 76 indexed citations
14.
Regine, William F., Nader Hanna, Michael Garofalo, et al.. (2007). Low-Dose Radiotherapy as a Chemopotentiator of Gemcitabine in Tumors of the Pancreas or Small Bowel: A Phase I Study Exploring a New Treatment Paradigm. International Journal of Radiation Oncology*Biology*Physics. 68(1). 172–177. 35 indexed citations
15.
Ye, Mao, Xiangjian Luo, Lili Li, et al.. (2007). Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Letters. 258(2). 199–207. 49 indexed citations
16.
Rodríguez‐Galindo, Carlos, Kristine R. Crews, Clinton F. Stewart, et al.. (2005). Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 57(1). 15–24. 15 indexed citations
17.
Ye, Mao, Ji‐Kai Liu, Zhongxin Lu, et al.. (2005). Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro. FEBS Letters. 579(16). 3437–3443. 82 indexed citations
18.
Bauer, Kenneth S., Judith E. Karp, Τushar Garimella, et al.. (2004). A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia. Leukemia Research. 29(3). 263–271. 19 indexed citations
19.
Kaste, Sue C., Ming Tan, William H. Meyer, et al.. (2001). Thallium bone imaging as an indicator of response and outcome in nonmetastatic primary extremity osteosarcoma. Pediatric Radiology. 31(4). 251–256. 9 indexed citations
20.
Zamboni, William C., Laura C. Bowman, Ming Tan, et al.. (1999). Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors. Cancer Chemotherapy and Pharmacology. 43(6). 454–460. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Stempak Breakdown of academic impact, for papers by Megumi Baba Breakdown of academic impact, for papers by Fei Cao Breakdown of academic impact, for papers by Claudio Zanna Breakdown of academic impact, for papers by Álmos Klekner Breakdown of academic impact, for papers by Miki Nishimura Breakdown of academic impact, for papers by Nektaria Makrilia Breakdown of academic impact, for papers by Christopher Mohr Breakdown of academic impact, for papers by Theodore Lagattuta Breakdown of academic impact, for papers by L.L. Miller
Rankless by CCL
2026